Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging.

Abstract:

:We report on the prevalence of dementia in Canadians age 85 years and older. The purpose of this study was to determine whether the prevalence of dementia continued to increase in the very old, and to define the types of dementia and their relative proportions in this age group. We collected data as part of the Canadian Study of Health and Aging (1990 to 1992), which consisted of a sample of 1,835 subjects from a population of 283,510 Canadians who were 85 years of age and older residing in the community or in institutions. The prevalence of dementia in the 85 years and older group was 28.5%, more than twice that of the 75- to 84-years cohort. The prevalence of dementia of 23% in the 85- to 89-years sample (n = 1,332) increased to 40% in the 90 to 94 years group (n = 371) and, in the 95 years and older sample (n = 104), reached 58%. Overall, Alzheimer's disease (AD; probable or possible) accounted for 75% of all dementias; a vascular etiology alone accounted for 13% of dementias. The proportion of clinically diagnosed AD cases to vascular dementia cases increased significantly after age 65 and was higher in the 85+ group than in a younger cohort (65 to 84 years).

journal_name

Neurology

journal_title

Neurology

authors

Ebly EM,Parhad IM,Hogan DB,Fung TS

doi

10.1212/wnl.44.9.1593

subject

Has Abstract

pub_date

1994-09-01 00:00:00

pages

1593-600

issue

9

eissn

0028-3878

issn

1526-632X

journal_volume

44

pub_type

杂志文章
  • Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design.

    abstract:OBJECTIVE:To use a historical placebo control design to determine whether lithium carbonate slows progression of amyotrophic lateral sclerosis (ALS). METHODS:A phase II trial was conducted at 10 sites in the Western ALS Study Group using similar dosages (300-450 mg/day), target blood levels (0.3-0.8 mEq/L), outcome me...

    journal_title:Neurology

    pub_type: 杂志文章,多中心研究

    doi:10.1212/WNL.0b013e31822dc7a5

    authors: Miller RG,Moore DH,Forshew DA,Katz JS,Barohn RJ,Valan M,Bromberg MB,Goslin KL,Graves MC,McCluskey LF,McVey AL,Mozaffar T,Florence JM,Pestronk A,Ross M,Simpson EP,Appel SH,WALS Study Group.

    更新日期:2011-09-06 00:00:00

  • Pharmacokinetics, pharmacodynamics, and tolerability of tolcapone: a review of early studies in volunteers.

    abstract::Tolcapone is a potent, reversible inhibitor of catechol O-methyltransferase (COMT) intended for use as an adjunct to levodopa therapy for Parkinson's disease (PD). Findings from the first pharmacokinetics/pharmacodynamics and tolerability studies of tolcapone in volunteers are reviewed. Following linear and dose-propo...

    journal_title:Neurology

    pub_type: 杂志文章,评审

    doi:10.1212/wnl.50.5_suppl_5.s31

    authors: Jorga KM

    更新日期:1998-05-01 00:00:00

  • Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group.

    abstract::The association of the human leukocyte antigen (HLA)-DR2 allele with brain MRI signal abnormalities and with the development of MS was assessed in 178 patients enrolled in the Optic Neuritis Treatment Trial. HLA haplotype DR2 was present in 85 (48%) of the 178 patients. Its presence was associated with increased odds ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.54.9.1859

    authors: Hauser SL,Oksenberg JR,Lincoln R,Garovoy J,Beck RW,Cole SR,Moke PS,Kip KE,Gal RL,Long DT

    更新日期:2000-05-09 00:00:00

  • Botulinum toxin for blepharospasm: single-fiber EMG studies.

    abstract::In four patients who received periocular injections of botulinum toxin for blepharospasm, abnormal neuromuscular transmission was demonstrated by single-fiber EMG in arm muscles. The time course with which the abnormalities developed and cleared, as well as the inverse relationship between the neuromuscular jitter and...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.36.4.545

    authors: Sanders DB,Massey EW,Buckley EG

    更新日期:1986-04-01 00:00:00

  • Abnormal perception of vibration-induced illusion of movement in dystonia.

    abstract:OBJECTIVES:To examine the illusional sensation of movement evoked by vibration of an immobilized arm. METHODS:Patients with idiopathic focal dystonia were compared with those with idiopathic PD and with patients with dystonia secondary to PD. A 100-Hz transcutaneous vibratory stimulus was applied to the biceps brachii...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.53.8.1794

    authors: Rome S,Grünewald RA

    更新日期:1999-11-10 00:00:00

  • Evidence in focus: Nusinersen use in spinal muscular atrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

    abstract:OBJECTIVE:To identify the level of evidence for use of nusinersen to treat spinal muscular atrophy (SMA) and review clinical considerations regarding use. METHODS:The author panel systematically reviewed nusinersen clinical trials for patients with SMA and assigned level of evidence statements based on the American Ac...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000006502

    authors: Michelson D,Ciafaloni E,Ashwal S,Lewis E,Narayanaswami P,Oskoui M,Armstrong MJ

    更新日期:2018-11-13 00:00:00

  • Estrogen treatment of dyskinetic disorders.

    abstract::Estrogen have been reported in animal studies to both enhance and block central dopaminergic activity and in one clinical report to improve tardive dyskinesia. In the present study estrogen (Premarin, 2.5 mg per day) administration caused varying degrees of improvement in less than one-third of 21 patients with chorea...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1212/wnl.32.5.547

    authors: Koller WC,Barr A,Biary N

    更新日期:1982-05-01 00:00:00

  • Pergolide in the treatment of Parkinson's disease.

    abstract::Pergolide, a long-acting central dopamine agonist, was used as monotherapy in 16 parkinsonian patients. A mean daily dose of 6.3 mg resulted in 73% improvement of parkinsonian disability. Clinical improvement after acute administration of one dose of pergolide was similar to that observed after levodopa plus a periphe...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.34.7.983

    authors: Mear JY,Barroche G,de Smet Y,Weber M,Lhermitte F,Agid Y

    更新日期:1984-07-01 00:00:00

  • Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.

    abstract:OBJECTIVE:It has been suggested that anemia may be a risk factor for dementia, for restless legs syndrome, and for Parkinson disease (PD). Thus, we investigated the association of anemia with the subsequent risk of PD using a case-control study design. METHODS:We used the medical records-linkage system of the Rocheste...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e3181bd80c1

    authors: Savica R,Grossardt BR,Carlin JM,Icen M,Bower JH,Ahlskog JE,Maraganore DM,Steensma DP,Rocca WA

    更新日期:2009-10-27 00:00:00

  • Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy.

    abstract:OBJECTIVE:To investigate the risk factors of neutralizing antibody (NAB)-induced complete secondary treatment failure (cSTF) during long-term botulinum neurotoxin (BoNT) treatment in various neurologic indications. METHODS:This monocenter retrospective cohort study analyzed the data of 471 patients started on BoNT the...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000009444

    authors: Walter U,Mühlenhoff C,Benecke R,Dressler D,Mix E,Alt J,Wittstock M,Dudesek A,Storch A,Kamm C

    更新日期:2020-05-19 00:00:00

  • Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia.

    abstract:OBJECTIVE:We sought cognitive event-related potential (ERP) biomarkers of disease progression and subsequent conversion to dementia in mild cognitive impairment (MCI). BACKGROUND:Two ERP components, the P600 and N400, are sensitive to abnormal episodic/declarative memory and semantic processing. When congruous categor...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000281689.28759.ab

    authors: Olichney JM,Taylor JR,Gatherwright J,Salmon DP,Bressler AJ,Kutas M,Iragui-Madoz VJ

    更新日期:2008-05-06 00:00:00

  • Inverse cerebellum and occipital encephalocele. A dorsal fusion defect uniting the Arnold-Chiari and Dandy-Walker spectrum.

    abstract::The malformation of inverse cerebellum and occipital encephalocele is situated morphologically between the Arnold-Chiari and Dandy-Walker malformations. In the three reported cases, hydrocephalus was not present, concomitant malformations of the lamina terminalis were present in two, and polymicrogyria was found in al...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.27.3.246

    authors: Smith MT,Huntington HW

    更新日期:1977-03-01 00:00:00

  • Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy.

    abstract:OBJECTIVE:To investigate whether recurrent seizures cause hippocampal damage in temporal lobe epilepsy (TLE). PATIENTS:Eighteen patients with newly diagnosed cryptogenic TLE, 14 patients with chronic well-controlled cryptogenic TLE, 32 patients with chronic drug-resistant cryptogenic TLE, and 25 healthy subjects were ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.50.5.1377

    authors: Kälviäinen R,Salmenperä T,Partanen K,Vainio P,Riekkinen P,Pitkänen A

    更新日期:1998-05-01 00:00:00

  • Human brain, plasma, and cerebrospinal fluid concentration of sodium valproate after 72 hours of therapy.

    abstract::Nine neurosurgical patients suffering from a variety of brain tumors were studied. Sodium valproate was given for 3 days before surgery. At craniotomy, sections of brain and samples of cerebrospinal fluid (CSF) and plasma were obtained and assayed for sodium valproate concentrations. Brain levels were 6.8 to 27.9% of ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.31.4.486

    authors: Vajda FJ,Donnan GA,Phillips J,Bladin PF

    更新日期:1981-04-01 00:00:00

  • Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension.

    abstract:BACKGROUND:Elevated serum retinol, CSF retinol, and serum retinol binding protein (RBP) levels have been found in some patients with idiopathic intracranial hypertension (IIH), but serum and CSF retinol levels have not been studied in matched serum and CSF samples in patients with IIH. OBJECTIVE:To determine whether s...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.WNL.0000163556.31080.98

    authors: Tabassi A,Salmasi AH,Jalali M

    更新日期:2005-06-14 00:00:00

  • Imaging of neuroinflammation in migraine with aura: A [11C]PBR28 PET/MRI study.

    abstract:OBJECTIVE:To determine if migraine with aura is associated with neuroinflammation, which has been suggested by preclinical models of cortical spreading depression (CSD) as well as imaging of human pain conditions. METHODS:Thirteen migraineurs with aura and 16 healthy controls received integrated PET/MRI brain scans wi...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000007371

    authors: Albrecht DS,Mainero C,Ichijo E,Ward N,Granziera C,Zürcher NR,Akeju O,Bonnier G,Price J,Hooker JM,Napadow V,Loggia ML,Hadjikhani N

    更新日期:2019-04-23 00:00:00

  • Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype.

    abstract:BACKGROUND:Mutations in the early growth response 2 (EGR2) gene have recently been found in patients with congenital hypomyelinating neuropathy and Charcot-Marie-Tooth type 1 (CMT1) disease. OBJECTIVE:To determine the frequency of EGR2 mutations in patients with a diagnosis of CMT1, Dejerine-Sottas syndrome (DSS), or ...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.52.9.1827

    authors: Timmerman V,De Jonghe P,Ceuterick C,De Vriendt E,Löfgren A,Nelis E,Warner LE,Lupski JR,Martin JJ,Van Broeckhoven C

    更新日期:1999-06-10 00:00:00

  • Juvenile-onset glycogen storage disease type II with novel mutations in acid alpha-glucosidase gene.

    abstract::The authors describe two novel mutations of the acid alpha-glucosidase gene, P361L and R437C, which define the juvenile-onset glycogen storage disease type II (GSDII) in a 16-year-old Chinese patient. The asymptomatic 13-year-old brother of the proband is also a compound heterozygote of the two mutations. These result...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/01.wnl.0000048661.95327.bf

    authors: Lam CW,Yuen YP,Chan KY,Tong SF,Lai CK,Chow TC,Lee KC,Chan YW,Martiniuk F

    更新日期:2003-02-25 00:00:00

  • An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus.

    abstract::The authors report an autosomal dominant episodic ataxia that is clinically distinct from the other episodic ataxias. Vestibular ataxia, vertigo, tinnitus, and interictal myokymia are prominent; attacks are diminished by acetazolamide. Linkage analyses of markers flanking the EA1 and EA2 loci demonstrate genetic exclu...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.57.8.1499

    authors: Steckley JL,Ebers GC,Cader MZ,McLachlan RS

    更新日期:2001-10-23 00:00:00

  • Ictal motor signs and interictal regional cerebral hypometabolism.

    abstract::Early motor manifestations are the main components of focal seizures involving the frontal lobe. We examined the relationship between the initial ictal motor manifestations and interictal abnormalities of cerebral glucose consumption (rCMRGlc) as assessed by PET in 48 consecutive patients with focal seizures of neocor...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.49.2.341

    authors: Schlaug G,Antke C,Holthausen H,Arnold S,Ebner A,Tuxhorn I,Jäncke L,Lüders H,Witte OW,Seitz RJ

    更新日期:1997-08-01 00:00:00

  • Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients.

    abstract:OBJECTIVE:To determine the effect of interferon-beta-1b (IFNbeta-1b) treatment on total contrast-enhancing lesions (CEL), white matter lesion load (WMLL), and cerebral atrophy (CA) in patients with relapsing-remitting multiple sclerosis (RRMS) using serial monthly MRI. METHODS:An open-label baseline-vs-treatment cross...

    journal_title:Neurology

    pub_type: 临床试验,杂志文章

    doi:10.1212/01.wnl.0000113765.75855.19

    authors: Frank JA,Richert N,Bash C,Stone L,Calabresi PA,Lewis B,Stone R,Howard T,McFarland HF

    更新日期:2004-03-09 00:00:00

  • Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-up.

    abstract:OBJECTIVE:The aim of the study was to perform a third cognitive assessment in our pediatric-onset multiple sclerosis (MS) patient cohort and determine predictors of the individual cognitive outcome. METHODS:After 4.7 ± 0.7 years from baseline evaluation, 48 of 63 patients in the original cohort were reassessed on an e...

    journal_title:Neurology

    pub_type: 杂志文章,多中心研究

    doi:10.1212/WNL.0000000000000885

    authors: Amato MP,Goretti B,Ghezzi A,Hakiki B,Niccolai C,Lori S,Moiola L,Falautano M,Viterbo RG,Patti F,Cilia S,Pozzilli C,Bianchi V,Roscio M,Martinelli V,Comi G,Portaccio E,Trojano M,MS Study Group of the Italian Neurological

    更新日期:2014-10-14 00:00:00

  • Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy.

    abstract::The authors describe a patient with sporadic distal myopathy associated with reduced caveolin-3 in muscle fibers in which the muscle atrophy was restricted to the small muscles of the hands and feet. Gene analysis disclosed a heterozygous 80 G-->A substitution in the caveolin-3 gene that was identical to that of repor...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.58.2.323

    authors: Tateyama M,Aoki M,Nishino I,Hayashi YK,Sekiguchi S,Shiga Y,Takahashi T,Onodera Y,Haginoya K,Kobayashi K,Iinuma K,Nonaka I,Arahata K,Itoyama Y

    更新日期:2002-01-22 00:00:00

  • Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients.

    abstract::There are several reports of a defect of complex I in the substantia nigra (SN) of Parkinson's disease (PD) patients. To evaluate whether this is specific to dopaminergic neurons or the phenotypically relevant consequence of a widespread failure of the mitochondrial oxidative phosphorylation (OXPHOS) system, we measur...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.43.11.2262

    authors: DiDonato S,Zeviani M,Giovannini P,Savarese N,Rimoldi M,Mariotti C,Girotti F,Caraceni T

    更新日期:1993-11-01 00:00:00

  • MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis.

    abstract:OBJECTIVE:The authors imaged the medial longitudinal fasciculus (MLF) in 58 patients with MS and chronic internuclear ophthalmoparesis (INO) to determine which MRI technique best shows the characteristic lesion associated with this ocular motor syndrome. METHODS:Using quantitative infrared oculography, the authors det...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/wnl.57.5.762

    authors: Frohman EM,Zhang H,Kramer PD,Fleckenstein J,Hawker K,Racke MK,Frohman TC

    更新日期:2001-09-11 00:00:00

  • Prehospital selection of thrombectomy candidates beyond large vessel occlusion: M-DIRECT scale.

    abstract:OBJECTIVE:Current prehospital scales used to detect large vessel occlusion reveal very low endovascular thrombectomy (EVT) rates among selected patients. We developed a novel prehospital scale, the Madrid-Direct Referral to Endovascular Center (M-DIRECT), to identify EVT candidates for direct transfer to EVT-capable ce...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000008998

    authors: Rodríguez-Pardo J,Riera-López N,Fuentes B,Alonso de Leciñana M,Secades-García S,Álvarez-Fraga J,Busca-Ostolaza P,Carneado-Ruiz J,Díaz-Guzmán J,Egido-Herrero J,Gil-Núñez A,Masjuan-Vallejo J,Real-Martínez V,Vivancos-Mora J,Díez

    更新日期:2020-02-25 00:00:00

  • Implementing standardized provider documentation in a tertiary epilepsy clinic.

    abstract:OBJECTIVE:To incorporate standardized documentation into an epilepsy clinic and to use these standardized data to compare patients' perception of epilepsy diagnosis to provider documentation. METHODS:Using quality improvement methodology, we implemented interventions to increase documentation of epilepsy diagnosis, se...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0000000000009778

    authors: Jones FJS,Smith JR,Ayub N,Herman ST,Buchhalter JR,Fureman BE,Cash SS,Hoch DB,Moura LMVR

    更新日期:2020-07-14 00:00:00

  • Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.

    abstract:BACKGROUND:Both AD and normal aging cause brain atrophy, limiting the ability of MRI to distinguish between AD and age-related brain tissue loss. MRS imaging (MRSI) measures the neuronal marker N-acetylaspartate (NAA), which could help assess brain change in AD and aging. OBJECTIVES:To determine the effects of AD on c...

    journal_title:Neurology

    pub_type: 杂志文章,多中心研究

    doi:10.1212/wnl.58.6.928

    authors: Schuff N,Capizzano AA,Du AT,Amend DL,O'Neill J,Norman D,Kramer J,Jagust W,Miller B,Wolkowitz OM,Yaffe K,Weiner MW

    更新日期:2002-03-26 00:00:00

  • Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.

    abstract:OBJECTIVES:To assess the therapeutic efficacy, required dose, and tolerability of pregabalin in patients with idiopathic restless legs syndrome (RLS). METHODS:This was a double-blind, placebo-controlled trial with polysomnographic control, providing Class II evidence. Ninety-eight patients underwent a 2-week single-bl...

    journal_title:Neurology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1212/WNL.0b013e3181e1ce73

    authors: Garcia-Borreguero D,Larrosa O,Williams AM,Albares J,Pascual M,Palacios JC,Fernandez C

    更新日期:2010-06-08 00:00:00

  • International Classification of Diseases (ICD-11) and neurologic disorders: the future.

    abstract::When the WHO's Topic Advisory Group for Neurology (TAG) started work on revision of the ICD-10 diagnostic codes in June 2009, the issues were daunting. The existing classification was produced a generation ago and the need to move to the digital age was becoming imperative. Appreciating modern advances in genetics and...

    journal_title:Neurology

    pub_type: 杂志文章

    doi:10.1212/WNL.0b013e31829a333c

    authors: Shakir R,Bergen D

    更新日期:2013-07-09 00:00:00